Want to join the conversation?
For 3Q16, $PX expects the benefits from recent acquisitions and project start-ups to be mostly offset by seasonally lower volumes. The company assumes 3Q16 results to be same as 2Q16. Capital expenditures are anticipated to be about $1.4Bil for the year. Based on the current outlook, $PX said that it does not expect any type of recovery.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?